Abdul Basit, PhD, is Professor of Pharmaceutics at the University College London (UCL) School of Pharmacy. Professor Basit is a world leading authority on oral drug delivery, digital health, innovative pharmaceutical technologies, including 3D printing, and translational research. Professor Basit leads a large and multi-disciplinary research group, where his research sits at the interface between the microbiome, 3D printing of pharmaceuticals, digital health and gastro-enterology, forging links between basic science and clinical outcomes. He has founded two spin-out companies (FabRx and Intract Pharma) and has invented several drug products that have entered the clinic. He has published over 350 papers, book chapters, abstracts, and patents.
Don't miss
- Alessia Favaron successfully defending her PhD on how JAK inhibitor drugs for inflammatory bowel disease (IBD) interact with the human gut microbiome
- Outstanding cum laude! 1st COLOTAN PhD defence by Ines Pârente
- A new COLOTAN publication that explores the potential of human intestinal organoids
- A new COLOTAN published article for the better understanding of the luminal conditions in the proximal colon
- Best lecture (runner-up) award at the SoP Research Day goes to COLOTAN’s Alessia!